Gerrit Machetanz

855 total citations
13 papers, 487 citations indexed

About

Gerrit Machetanz is a scholar working on Neurology, Cognitive Neuroscience and Surgery. According to data from OpenAlex, Gerrit Machetanz has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 4 papers in Cognitive Neuroscience and 3 papers in Surgery. Recurrent topics in Gerrit Machetanz's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological diseases and metabolism (3 papers) and Autism Spectrum Disorder Research (3 papers). Gerrit Machetanz is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological diseases and metabolism (3 papers) and Autism Spectrum Disorder Research (3 papers). Gerrit Machetanz collaborates with scholars based in Germany, United States and Sweden. Gerrit Machetanz's co-authors include Julia C. Fitzgerald, Carola Rotermund, Stefanie Lerche, Isabel Wurster, Milan Zimmermann, Kathrin Brockmann, Walter Maetzler, Daniela Berg, Thomas Gasser and Marcel Naumann and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Neurobiology of Aging and Movement Disorders.

In The Last Decade

Gerrit Machetanz

13 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerrit Machetanz Germany	11	213	165	158	64	60	13	487
Carola Rotermund Germany	8	171 0.8×	219 1.3×	183 1.2×	83 1.3×	59 1.0×	12	549
Jiunn-Tay Lee Taiwan	9	157 0.7×	259 1.6×	188 1.2×	73 1.1×	105 1.8×	11	596
Olimpia E. Curran United Kingdom	9	109 0.5×	130 0.8×	70 0.4×	89 1.4×	37 0.6×	13	519
Márcia Mattos Gonçalves Pimentel Brazil	18	160 0.8×	365 2.2×	149 0.9×	88 1.4×	44 0.7×	65	852
Zifeng Huang China	16	170 0.8×	223 1.4×	83 0.5×	87 1.4×	131 2.2×	33	592
Maria A. Costa-Besada Spain	9	112 0.5×	215 1.3×	93 0.6×	151 2.4×	109 1.8×	11	578
Julie L. Chan United States	7	111 0.5×	197 1.2×	218 1.4×	71 1.1×	50 0.8×	23	507
Thomas Schwarzlmüller Norway	9	145 0.7×	168 1.0×	102 0.6×	92 1.4×	53 0.9×	15	547
Crissey L. Pascale United States	13	158 0.7×	139 0.8×	119 0.8×	90 1.4×	115 1.9×	18	518
Dexuan Ma China	13	64 0.3×	208 1.3×	85 0.5×	99 1.5×	30 0.5×	21	526

Countries citing papers authored by Gerrit Machetanz

Since Specialization

Citations

This map shows the geographic impact of Gerrit Machetanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Machetanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Machetanz more than expected).

Fields of papers citing papers by Gerrit Machetanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Machetanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Machetanz. The network helps show where Gerrit Machetanz may publish in the future.

Co-authorship network of co-authors of Gerrit Machetanz

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit Machetanz. A scholar is included among the top collaborators of Gerrit Machetanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit Machetanz. Gerrit Machetanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Müschen, Lars Hendrik, et al.. (2023). Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis. Cells. 12(5). 736–736. 33 indexed citations

Machetanz, Gerrit, et al.. (2023). Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen. Journal of Neuromuscular Diseases. 10(4). 719–725. 4 indexed citations

Machetanz, Gerrit, et al.. (2023). Parkinson’s disease therapy: what lies ahead?. Journal of Neural Transmission. 130(6). 793–820. 16 indexed citations

Zimmermann, Milan, Markéta Kovářová, Stefanie Lerche, et al.. (2021). The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease. European Journal of Neurology. 28(5). 1557–1565. 19 indexed citations

Lerche, Stefanie, Isabel Wurster, Milan Zimmermann, et al.. (2020). CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories. Movement Disorders. 35(7). 1138–1144. 35 indexed citations

Lerche, Stefanie, Gerrit Machetanz, Isabel Wurster, et al.. (2019). Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha‐synuclein profile. Movement Disorders. 34(7). 1069–1073. 24 indexed citations

Zimmermann, Milan, Isabel Wurster, Stefanie Lerche, et al.. (2019). Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderly. European Journal of Neurology. 27(1). 160–167. 19 indexed citations

Lerche, Stefanie, Isabel Wurster, Gerrit Machetanz, et al.. (2018). Parkinson’s disease: evolution of cognitive impairment and CSF Aβ_1–42 profiles in a prospective longitudinal study. Journal of Neurology Neurosurgery & Psychiatry. 90(2). 165–170. 17 indexed citations

Lerche, Stefanie, Gerrit Machetanz, Benjamin Röeben, et al.. (2018). Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD). Neurobiology of Aging. 70. 242–246. 15 indexed citations

10.

Sulzer, Patricia, Sara Becker, Walter Maetzler, et al.. (2018). Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson’s disease patients. Journal of Neurology. 265(9). 1976–1984. 6 indexed citations

11.

Rotermund, Carola, Gerrit Machetanz, & Julia C. Fitzgerald. (2018). The Therapeutic Potential of Metformin in Neurodegenerative Diseases. Frontiers in Endocrinology. 9. 400–400. 231 indexed citations

12.

Lerche, Stefanie, Inga Liepelt‐Scarfone, Isabel Wurster, et al.. (2018). Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease. Movement Disorders. 33(8). 1349–1353. 10 indexed citations

13.

Schormair, Barbara, David Kemlink, Brit Mollenhauer, et al.. (2017). Diagnostic exome sequencing in early‐onset Parkinson's disease confirms VPS13C as a rare cause of autosomal‐recessive Parkinson's disease. Clinical Genetics. 93(3). 603–612. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact